Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CAM-101 by Cambium Bio for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
CAM-101 is under clinical development by Cambium Bio and currently in Phase II for Keratoconjunctivitis Sicca (Dry Eye). According to...